Correlation between cancer stem cells and circulating tumor cells and their value

Case Reports in Oncology

Volumn 4, Issue 1, 2011, Pages 44-54

  Toloudi, Maria ^a   Apostolou, Panagiotis ^a   Chatziioannou, Marina ^a   Papasotiriou, Ioannis ^a,b  

^a Research Genetic Cancer Center RGCC Ltd   (Greece)

^b NONE   (Greece)

Author keywords

Breast cancer; Cancer stem cell like cells; Circulating tumor cells

Indexed keywords

MICROSPHERE; TRANSCRIPTION FACTOR NANOG; TUMOR MARKER;

ADULT; ARTICLE; CANCER CELL; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENESIS; CASE REPORT; CELL ASSAY; CELL GROWTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYPOTHESIS; PHENOTYPE; PRIORITY JOURNAL; SUSPENSION CELL CULTURE;

EID: 79957605474     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000324403     Document Type: Article

References (30)

1. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW: Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005;23:1420-1430.
2. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller M C, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-791. (Pubitemid 39095313)
3. Hayes DF, Smerage J: Is there a role for circulating tumor cells in the management of breast cancer? Clin Cancer Res 2008;14:3646-3650
4. Tibbe AG, Miller MC, Terstappen LW: Statistical considerations for enumeration of circulating tumor cells. Cytometry A 2007;71:154-162. (Pubitemid 46355340)
5. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu G, Birnbaum D, Wicha MS: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009;69:1302-1313.
6. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-9344. (Pubitemid 44623625)
7. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003;113:643-655. (Pubitemid 36694189)
8. Zieglschmid V, Hollmann C, Mannel J, Albert W, Jaeschke-Melli S, Eckstein B, Hillemann T, Greten TF, Gross E, Bocher O: Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer. Anticancer Res 2007;27:1823-1832. (Pubitemid 46954682)
9. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313-323. (Pubitemid 47355323)
10. Kalluri R, Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-1428.
11. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-715. (Pubitemid 351636299)
12. Sanchez-Garcia I, Vicente-Duenas C, Cobaleda C: The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice? Bioessays 2007;29:1269-1280. (Pubitemid 350221795)
13. Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC: Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer 2009;9:20.
14. Tien YW, Jeng YM, Hu RH, Chang KJ, Hsu SM, Lee PH: Intravasation-related metastatic factors in colorectal cancer. Tumour Biol 2004;25:48-55.
15. Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S: Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 2009;11:R46.
16. Hill RP: Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 2006;66:1891-1895; discussion 1890.
17. Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Janicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K: Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007;13:920-928. (Pubitemid 46340368)
18. Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R, Kasimir-Bauer S: Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res 2009;11:R59.
19. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo J F: Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008;14:4085-4095.
20. Hattori N, Imao Y, Nishino K, Ohgane J, Yagi S, Tanaka S, Shiota K: Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells 2007;12:387-396. (Pubitemid 46359591)
21. Li C, Lee CJ, Simeone DM: Identification of human pancreatic cancer stem cells. Methods Mol Biol 2009;568:161-173.
22. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-1037.
23. Tewes M, Aktas B, Welt A, Mueller S, Hauch S, Kimmig R, Kasimir-Bauer S: Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res Treat 2009;115:581-590.
24. Marrinucci D, Bethel K, Lazar D, Fisher J, Huynh E, Clark P, Bruce R, Nieva J, Kuhn P: Cytomorphology of circulating colorectal tumor cells: a small case series. J Oncol 2010;2010:861341.
25. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyn D, Terstappen LW, Fehm T, Tucker TF, Lane N, Wang J, Uhr JW: Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004;10:8152-8162. (Pubitemid 40053373)
26. Lankiewicz S, Zimmermann S, Hollmann C, Hillemann T, Greten TF: Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer. Mol Oncol 2008;2:349-355.
27. Dick JE: Breast cancer stem cells revealed. Proc Natl Acad Sci USA 2003;100:3547-3549. (Pubitemid 36418067)
28. Hauch S, Zimmermann S, Lankiewicz S, Zieglschmid V, Bocher O, Albert WH: The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients. Anticancer Res 2007;27:1337-1341. (Pubitemid 46807280)
29. Jung M, Peterson H, Chavez L, Kahlem P, Lehrach H, Vilo J, Adjaye J: A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells. PLoS One 2010;5:e10709.
30. Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, Ng HH, Robson P: Transcriptional regulation of Nanog by OCT4 and SOX2. J Biol Chem 2005;280:24731-24737. (Pubitemid 40934562)